Business
Press Release Apr 05 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated April 05, 2021, titled "Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated April 05, 2021, titled \"Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b in treating COVID-19\". View Attachment","length":354,"tagName":"div"}]